Immunovia, Inc. Receives Approval to Begin Testing Patients for Pancreatic Cancer with the IMMray PanCan-d Test
Immunovia AB is developing and commercializing highly accurate blood tests for the early detection of cancer and autoimmune…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
05 Aug 21
Immunovia AB is developing and commercializing highly accurate blood tests for the early detection of cancer and autoimmune…
04 Aug 21
Philips and NYU Langone Health Department of Pathology, a premier NCI (National Cancer Institute) designated comprehensive cancer center,…
03 Aug 21
InterVenn intends to use the funding to expand its AI-driven glycoproteomics platform and its liquid biopsy assay dubbed…
02 Aug 21
M6-C disc is indicated as an alternative to cervical fusion to restore physiologic motion to the spine
02 Aug 21
The software consists of a solution for automated body segmentation and marking, quantifying and reporting suspicious lesions
30 Jul 21
Exo will use the funding to commercialise its handheld ultrasound device and workflow platform Exo Works for medical…
29 Jul 21
The financing will help advance the development of Strata’s personalised minimal residual disease assay for early-stage cancers
29 Jul 21
Will enable cancer researchers to accelerate identification and optimization of therapeutic leads by better decoding KRAS mutations present…
28 Jul 21
The SeleCT QCT service will streamline and optimise the screening process used to identify patients eligible to receive…
27 Jul 21
The Prevail DCB is designed to treat narrowed or blocked coronary arteries in patients with coronary artery disease